問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
China Medical University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2016-12-01 - 2019-12-31
Condition/Disease
Relapsed or Refractory Multiple Myeloma
Test Drug
Venetoclax (ABT-199)
Participate Sites5Sites
Terminated4Sites
Division of Hematology & Oncology
2023-08-01 - 2027-04-01
-
Participate Sites3Sites
Recruiting3Sites
2023-11-01 - 2030-12-31
Participate Sites6Sites
Not yet recruiting4Sites
Recruiting2Sites
2023-12-01 - 2027-12-31
Participate Sites9Sites
Recruiting9Sites
2018-01-01 - 2020-12-31
Participate Sites2Sites
Not yet recruiting2Sites
2019-04-01 - 2022-12-31
Participate Sites8Sites
Recruiting1Sites
Terminated7Sites
2020-11-30 - 2025-12-31
2021-03-01 - 2023-12-31
Terminated5Sites
2021-04-01 - 2024-03-01
Participate Sites4Sites
Recruiting4Sites
2021-11-01 - 2022-08-29
Recruiting6Sites
全部
